Previous Article | Next Article 
Infection and Immunity, June 2001, p. 4094-4102, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.4094-4102.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immunohistochemical Analysis of Lyme Disease in the Skin of Naive
and Infection-Immune Rabbits following Challenge
Celeste
Chong-Cerrillo,1,
Ellen S.
Shang,1
David R.
Blanco,1,2
Michael A.
Lovett,1,2 and
James N.
Miller1,*
Department of Microbiology and
Immunology,1 and Division of Infectious
Disease, Department of Medicine,2 University
of California, School of Medicine, Los Angeles, California 90095
Received 20 December 2000/Returned for modification 1 February
2001/Accepted 2 March 2001
 |
ABSTRACT |
In this study, skin histopathology from naive and infection-derived
immune rabbits was compared following intradermal challenge using
Borrelia burgdorferi B31 strain. The presence or absence of
spirochetes in relationship to host cellular immune responses was
determined from the time of intradermal inoculation to the time of
erythema migrans (EM) development (~7 days in naive rabbits) and
through development of challenge immunity (~5 months in
naive rabbits). Skin biopsies were obtained and analyzed for the
presence of spirochetes, B cells, T cells, polymorphonuclear
cells (PMNs), and macrophages by immunohistochemical techniques.
In infected naive animals, morphologically identifiable
spirochetes were detected at 2 h and up to 3 weeks
postinfection. At 12 and 24 h postinfection there was a marked
PMN response that decreased by 36 to 48 h; by 72 h the PMNs
were replaced by a few infiltrating macrophages. At the time of EM
development and 14 days postinfection, the PMNs and
macrophages were replaced by a lymphocytic infiltrate. There was
a greater number of spirochetes at 14 days, a time when EM had
resolved, than at 7 days postinfection. By 3 weeks postinfection there
were few organisms and lymphocytes detectable. In contrast to infected
naive rabbits, intact spirochetes were never visualized in skin
biopsies from infection-immune rabbits; only spirochetal antigen was
detected at 2, 12, and 24 h in the presence of a numerous PMN
infiltrate. By 36 h postchallenge, spirochetal antigen could not
be detected and the PMN response was replaced by a few infiltrating macrophages. By 72 h postchallenge, PMNs and macrophages were absent from the skin; B and T cells were never detected at any time
point in skin from infection-immune rabbits. The destruction of
spirochetes in immune animals in the presence of PMNs and in the
absence of a lymphocytic infiltrate suggests that infection-derived immunity is antibody mediated.
 |
INTRODUCTION |
Lyme disease is the most common
vector-borne disease in the United States (28). The
disease is transmitted to humans by the bite of an infected
Ixodes tick harboring either Borrelia burgdorferi
sensu stricto, B. afzelii, or B. garinii, related spirochetes collectively termed B. burgdorferi sensu lato.
In the majority of patients, Lyme disease is characterized by
the initial appearance of a rash-like skin lesion termed erythema migrans (EM) (39, 42). Early and late clinical
manifestations include arthritis, neurological manifestations,
lymphadenopathy, and carditis, which reflects dissemination to visceral
targets (1, 16, 24, 29, 30, 34, 38, 40-43). Although Lyme disease is rarely fatal, it can be quite debilitating.
Implicit in the development of an effective vaccine against Lyme
disease is a thorough understanding of the pathogenetic
mechanisms as well as the host immune response operative
during host-spirochete interaction. In the murine model
of Lyme disease, the histopathology is characterized by a lymphocytic
and plasma cell infiltration, occasional perivascular cuffing,
and few or no detectable macrophages (8, 13, 18, 27, 32,
37). BALB/c and C3H mice have been used in elucidating the
immune response of the host following infection with B. burgdorferi. Humoral immunity has been shown to play a major role
in resistance to Lyme disease, although cellular immunity has also been
demonstrated to influence the outcome of arthritis severity and
infection (4-6, 20-23, 25, 26, 33, 47, 48). However, a
direct relationship between the spirochetes and host immune cells has
not been demonstrated. In addition, the chronic nature of the disease
in the murine model precludes determining the immune mechanisms
involved in clearance of organisms and resolution of the disease.
The rabbit model of Lyme disease has unique features relevant to
the immunobiology of B. burgdorferi infection. It is
the only animal model besides the rhesus monkey (31)
that reproducibly results in EM that is indistinguishable from that of
human disease after intradermal inoculation of B. burgdorferi sensu stricto (15). Most importantly,
untreated skin and visceral infection is ultimately cleared, resulting
in complete immunity against reinfection with up to 2 × 107 challenge organisms (15). Thus, in the
rabbit model of Lyme disease, it is possible to examine the effective
host immune factors, humoral and cellular, associated with acquired
resistance against infection with B. burgdorferi.
In the current study, we directed our efforts toward elucidating the
outcome of host-spirochete interaction following the intradermal
inoculation of naive and infection-derived immune rabbits with
B. burgdorferi B31 from the time of intradermal inoculation to the time of EM development and through development of
challenge immunity. We specifically addressed the location and
persistence of spirochetes in relationship to the presence and
distribution of polymorphonuclear cells (PMNs), macrophages, T cells,
and B cells in an effort to determine the potential cellular mechanisms responsible for pathogenesis and host immunity.
 |
MATERIALS AND METHODS |
Animals.
Adult, male, New Zealand White rabbits 6 to 9 months of age (Irish Farms, Norco, Calif.) were housed individually in
a temperature-controlled environment ranging from 18 to 21°C. Prior
to intradermal (i.d.) inoculation with B. burgdorferi, the
backs of the rabbits were clipped closely with an electric clipper
fitted with a size 40 blade to expose the skin (Oster Professional
Products, McMinnville, Tenn.).
Male C3H/HeJ mice 6 weeks of age were purchased from Jackson
Laboratories (Bar Harbor, Maine) and housed in cages containing no more
than five animals.
Bacterial strains and preparation of inocula for infection and
challenge.
Virulent B. burgdorferi sensu stricto,
strain B31, was isolated from infected rabbit tissue, grown in BSK II
medium (7) to maximum density, and then passaged twice
more in fresh BSK II medium. After the final passage (passaged two
times), the organisms were centrifuged gently at 8,000 × g for 10 min and washed three times in heat-inactivated (56°C
for 30 min) normal rabbit serum (NRS), diluted 1:1 with
phosphate-buffered saline (PBS; pH 7.2) (NRS-PBS), in order to remove
foreign protein components responsible for nonspecific reactions in the
rabbit (15, 36). Inocula for infection and challenge were
resuspended in NRS-PBS after the final wash to a final concentration
containing 107 or 108 B. burgdorferi per ml depending on the experiment. As in previously published experiments (15, 36), the spirochetes in the
final suspension were motile and virulent.
Generation and challenge of infection-derived immune
rabbits.
Based on previous studies in which a high degree of
infection-derived immunity to challenge was established
(15), rabbits were infected i.d. with doses ranging from
6 × 106 to 8 × 107 B. burgdorferi depending on the experiment. Inocula were administered in 0.1-ml doses at several sites. Six months after infection, at a time
when EM lesions had healed, dermal infection was absent and, on the
basis of our previously described studies, visceral dissemination was
no longer demonstrable (15), the rabbits were challenged
i.d. with doses ranging from 107 to 108
B. burgdorferi depending on the experiment. In addition,
naive rabbits were inoculated in the same manner to serve as controls.
Skin biopsy and culture.
Skin punch biopsies were obtained
from all experimental and control rabbits at various time points
postinfection (p.i.) and postchallenge (p.c.). Rabbits were
anesthetized by intramuscular injection with 45 mg of Ketaset (Fort
Dodge Laboratories, Fort Dodge, Iowa) and 8.8 mg of Xylazine (Lloyd
Laboratories, Shenandoah, Iowa) per kg of body weight. A 4- to 5-mm
sterile punch biopsy (Baker and Cummings, Lakewood, N.J.) was taken
adjacent to the inoculation site from the clipped back of each rabbit.
Each biopsy specimen was immediately minced and cultured in 5 ml of BSK
II medium containing 100 µg of phosphomycin per ml and 50 µg of
rifampin per ml (Sigma, St. Louis, Mo.).
Cultures were incubated aerobically at 34°C for a period of 7 weeks,
and the presence or absence of B. burgdorferi was determined periodically by dark-field microscopy. Cultures were considered negative when no sprochetes were observed during the 7-week observation period.
Preparation of polyclonal mouse anti-B. burgdorferi
immunoglobulin G (IgG) for immunohistochemical detection of B. burgdorferi in skin sections.
Virulent B. burgdorferi was grown as described above to passage 3. Organisms
were washed three times by suspension in PBS followed by centrifugation
at 8,000 × g for 10 min. After the final wash,
organisms were resuspended in PBS to a final volume containing
1010 B. burgdorferi per ml. The organisms were
then disrupted by ultrasonic treatment and stored at
80°C until
ready for use.
Twenty C3H/HeJ mice were hyperimmunized with the above-prepared
suspensions of B. burgdorferi. For the initial immunization, an equal volume of organisms (ca. 100 µl) was mixed 1:1 with complete Freund adjuvant (Calbiochem Corp., La Jolla, Calif.) and administered subcutaneously (s.c.). Two booster immunizations at 4-week intervals were also given s.c. using 100 µl of the B. burgdorferi
suspension mixed 1:1 with incomplete Freund adjuvant (Calbiochem
Corp.). Four weeks after the final boost immunization, all mice were
euthanized and blood obtained by cardiac puncture. The sera were then
pooled and the IgG fraction was isolated by fast-performance liquid
chromatography using a protein A-Superose column (HR 10/2; Pharmacia
Biotech, Uppsala, Sweden). As determined by enzyme-linked immunosorbent assay, the isolated IgG fraction was found to have an anti-B. burgdorferi titer of 1:16,000 and was reactive to all Amido
black-stained B. burgdorferi antigens as determined by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by
immunoblot analysis (data not shown).
Immunohistochemical staining of skin biopsies.
Skin punch
biopsies of 4 to 5 mm were obtained from all experimental and control
rabbits at various time points p.i. and p.c. The punch biopsies were
embedded in O.C.T. compound (Sakura Finetek, U.S.A., Inc., Torrance,
Calif.) and quick-frozen in a dry-ice-2-methylbutane bath. Skin punch
biopsies from naive rabbits were also obtained and frozen in O.C.T.
compound to serve as negative controls for immunohistochemical
staining. Frozen O.C.T.-embedded skin specimens were kept at
80°C
until ready for use.
Frozen test and control skin biopsy specimens were cut into
4-µm-thick serial sections in a cryostat, collected on Superfrost Plus glass slides (Fisher Scientific, Pittsburgh, Penn.), and fixed
with cold acetone for 20 min. Sections were allowed to air dry then
incubated in Tris-buffered saline (TBS) for 5 min. Endogenous peroxidase activity was blocked by incubation with 3%
H2O2 for 5 min at room temperature. Sections
were rinsed well with double-distilled water (ddH2O)
followed by incubation in TBS for 5 min. Sections were then blocked
with Blotto (5% nonfat dry milk, 1% normal horse serum, and 0.2%
sodium azide in TBS) at room temperature for 30 min. After the blocking
step, five serial sections were incubated at 4°C overnight with
primary antibodies as follows. For the detection of B. burgdorferi, sections were incubated with a 1:5,000 dilution in
Blotto of polyclonal mouse anti-B. burgdorferi IgG; for
the detection of B cells, T cells, and PMNs or macrophages, sections were incubated with a 1:50 dilution in Reagent Diluent (0.5% bovine serum albumin in TBS) of purified mouse anti-rabbit CD79a monoclonal antibody (MAb), purified mouse anti-rabbit CD3 MAb, or purified mouse
anti-rabbit CD11b MAb (Spring Valley Laboratories, Inc., Woodbine,
Md.), respectively. After three washes of 5 min each with PBS
containing 0.02% Tween 20 (PBS-Tween), the sections were incubated
with horse anti-mouse IgG conjugated to biotin (Vector Laboratories,
Burlingame, Calif.) diluted 1:200 in PBS-Tween containing 1.5% NHS at
37°C for 30 min. Sections were then washed three times with PBS-Tween
followed by incubation with streptavidin peroxidase (Vector ABC Elite
kit; Vector Laboratories) at 37°C for 30 min. Sections were washed
once with PBS-Tween and then twice with ddH2O, and the
color was developed with 3-amino-9-ethyl-carbazole (AEC Chromogen Kit;
Biomeda Corp., Foster City, Calif.) at 37°C for 10 min. The reaction
was stopped by washing sections in ddH2O, and then the
sections were counterstained with a 1- to 2-min incubation in aqueous
hematoxylin (Biomeda Corp.). After a counter staining, the sections
were rinsed well in running tap water and then mounted with
Crystal/Mount (Biomeda Corp.), followed by the addition of a coverslip.
Frozen serial sections of each skin biopsy specimen were also stained
with hematoxylin and eosin (H&E) for histopathological examination.
 |
RESULTS |
Detection of B. burgdorferi and characterization
of the cellular infiltrate during EM in the skin of naive rabbits
following infection.
To identify and characterize the cellular
immune response in the development and resolution of EM, rabbits were
infected i.d. with 107 B. burgdorferi, and
representative skin biopsies were obtained at the time of EM
development (day 7 p.i) and EM resolution (day 14 p.i.).
Frozen serial sections of skin biopsies were analyzed for the presence
of B. burgdorferi, B cell, T cells, and
CD11b+ PMNs or macrophages by immunohistochemical staining.
In addition, skin biopsy samples were analyzed for the presence of
B. burgdorferi by culture in BSK II medium. As
presented in Table 1, all rabbits developed culture-positive EM lesions at day 7 p.i. At day 14 p.i., EM lesions had resolved, but all animals remained skin culture positive. Histological examination showed the presence of intact spirochetes at day 7 which increased in relative numbers by day 14 p.i. (Fig. 1). At the time of the
appearance of EM lesions that contained intact spirochetes (day 7 p.i.), there was predominantly a lymphocytic B-cell infiltration with
fewer T cells (Fig. 2). By comparison,
CD11b+ cells representing PMNs were only occasionally
detected in these sections (Table 1). The type and relative quantity of
the cellular infiltrate did not differ at day 14 (data not shown) from
that of day 7 even though the number of B. burgdorferi
was greater at day 14.

View larger version (143K):
[in this window]
[in a new window]
|
FIG. 1.
Immunohistochemical staining for the detection of
B. burgdorferi in skin biopsies from infected naive
rabbits at the time of EM development (7 days p.i.) (a) and at the time
of EM resolution (14 days p.i.) (b). Magnification, ×78.
|
|

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 2.
Immunohistochemical staining of skin biopsies from
infected naive rabbits at the time of EM development (7 days p.i.).
Serial skin sections were stained for B. burgdorferi
(a), B-cell lymphocytes (b), and T-cell lymphocytes (c). Magnification,
×125.
|
|
Skin histopathology in rabbits during initial infection and through
the development of immunity.
Based on previous studies, rabbits
infected i.d. 5 months earlier with B. burgdoreri B31
develop complete immunity to challenge reinfection (15).
To investigate the role of cellular immunity in the progression and
resolution of disease, rabbits were infected i.d. with 6 × 106 to 9 × 106 B. burgdorferi, and representative skin biopsies were obtained at 3 and 13 weeks p.i. and again at 24 weeks p.i. when immunity was
established. Frozen serial sections of skin biopsies were analyzed by
immunohistochemical staining, as described above, and skin biopsy
samples were cultured in BSK II medium for detection of viable
B. burgdorferi. At 3 weeks p.i., as shown in Table
2, 80% of rabbits had culture-positive
skin. Immunohistochemical detection showed that, compared to day
14 p.i. (Table 1), the quantity of spirochetes, B cells, and T
cells had decreased. By 13 weeks p.i. as well as by 24 weeks p.i.,
spirochetes were no longer histochemically detectable nor could they be
cultured from the skin (Table 2). In addition, lymphocytes were also
not detected from skin sections; only rarely were macrophages detected
at week 13 p.i. These data are consistent with our previous
observations demonstrating that by 5 to 6 months p.i., skin and
visceral infection in untreated rabbits is cleared (15).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Histopathology in B. burgdorferi-infected
rabbit skin during disease progession and development of immunity
|
|
Comparative histopathology in the skin immediately following
challenge of naive and infection-immune rabbits.
To examine early
cell mediated immune events following challenge of immune animals,
infection-derived immune rabbits previously infected with 8 × 107 B. burgdorferi were challenged i.d.
with 8 × 107 organisms, and representative skin
biopsies were obtained at 2, 12, 24, 36, 48, 72, and 96 h p.c. To
compare these early events to those which occur in the nonimmune animal
and to more thoroughly investigate immune mechanisms immediately
following infection, naive rabbits were inoculated in the same manner,
and representative skin biopsies obtained at the same time points as
above. Serial sections of skin biopsies were analyzed by
immunohistochemical staining and for the presence of viable
B. burgdorferi by culture in BSK II medium as before.
In naive animals, B. burgdorferi could be cultured from
skin and detected by immunohistochemical staining at each time point p.i. The detection of morphologically intact spirochetes in the skin by
immunohistochemical staining at the 36 h p.i. time point, as shown
in Fig. 3c and d, was typical of all time
points in infected naive rabbits. At 12 and 24 h p.i. there was a
marked PMN response which decreased slightly by 36 to 48 h p.i.
(Table 3 and Fig. 3e and f). By 72 and
96 h the PMNs were replaced by a few infiltrating macrophages.
Overall, there was a mild inflammatory response at these time points.
No lymphocytes were evident at any of the above time points (data not
shown); however, as mentioned earlier, the appearance of lymphocytes
did occur at the time of EM development (day 7 p.i.).

View larger version (150K):
[in this window]
[in a new window]
|
FIG. 3.
Immunohistochemical staining of skin biopsies from
infected naive rabbits 36 h p.i. Serial skin sections were stained by H
& E (a and b), for B. burgdorferi (c and d), and for
the CD11b PMN/macrophage marker (e and f). Magnification is at ×31 (a,
c, and e) and ×125 (b, d, and f) from an outlined area of panels a, c,
and e, respectively.
|
|
By comparison to the naive animals, skin biopsies from
infection-derived immune rabbits were culture positive only up to
36 h p.c. (Table 4), while at
48 h dermal infection was not detected in the skin biopsies
examined. Immunohistochemical analysis showed that while B. burgdorferi antigen could be detected at 2, 12, and 24 h p.c.
(Table 4 and Fig. 4c and d),
morphologically intact spirochetes were never observed in these biopsy
sections compared to the infected naive animals (compare Fig. 4d with
Fig. 3d). In addition, there was a marked PMN response at 12 and
24 h p.c. in immune animals similar to that observed in the
infected naive rabbits (Table 4 and Fig. 4e and f); the PMNs were
replaced by a sparse infiltrate of macrophages at 36 and 48 h p.c.
(data not shown). By 72 h p.c. no inflammatory cells could be
detected in the skin (data not shown). In addition, no lymphocytes were
detected at any of the above time points in the challenged
infection-immune animals. Further, skin biopsies obtained from 15 additional infection-immune rabbits at weeks 1 and 2 weeks p.c. were,
as expected, culture negative (data not shown).
Immunohistochemical staining of these 1-week p.c. sections showed no
intact spirochetes, only sparse detectable B. burgdorferi antigen and sparse detectable PMNs (data not shown).

View larger version (169K):
[in this window]
[in a new window]
|
FIG. 4.
Immunohistochemical staining of skin biopsies from
infection-immune rabbits 24 h after i.d. challenge with B. burgdorferi. Serial skin sections were stained by H & E (a and b),
for B. burgdorferi (c and d), and for the CD11b
PMN/macrophage marker (e and f). Magnification is at ×31 (a, c, and e)
and ×125 (b, d, and f) from an outlined area of a, c, and e,
respectively. Note that similar results were obtained from serial skin
sections of biopsies taken at 2 and 12 h p.c. (data not shown).
|
|
 |
DISCUSSION |
In this study we compared the cellular events, including the
morphological detection of spirochetes, in the skin of naive and
infection-derived immune rabbits following i.d. challenge with
B. burgdorferi B31. The observations made encompass the
time from inoculation to the development of EM and through the
development of challenge immunity. In the early events following the
infection of naive animals, morphologically identifiable spirochetes
were readily detected at 2 h and through 3 weeks p.i., which
paralleled the demonstration of culture-positive skin infection during
this time. We have recently reported, using quantitative PCR, that over
108 borreliae are present per cm2 of EM
biopsied skin (36), which indicates that the rabbit is a
very permissive host during the early course of infection. At 13 weeks
p.i., however, skin cultures were consistently negative and no intact
spirochetes could be detected by immunohistochemical staining. By
comparison, skin samples from infection-immune animals following
challenge never showed intact spirochetes; only B. burgdorferi antigen was detected at 2, 12, and 24 h p.c.,
which could no longer be detected at 36 h. In addition,
culture-positive samples were no longer demonstrable from these immune
rabbits after the 36-h time point. These findings demonstrate that the
infection-derived immunity that develops in experimental rabbit Lyme
disease rapidly destroys spirochetes at the site of challenge, as
evidenced by the loss of spirochetal morphology and viability.
In order to determine whether specific cell-mediated immune mechanisms
contribute to the immunity against challenge that develops in rabbits,
immunohistochemical analysis to identify infiltrating PMNs,
macrophages, T cells, and B cells was performed. In parallel, the same
analysis of naive rabbits following challenge was performed for
comparison to that of the immune animals and to characterize the
cellular response that occurs from the start of infection to the
development of immunity. It was observed that immediately following
challenge of either naive or infection-immune rabbits an influx of PMNs
occurred and were most prominently present at 12 and 24 h. This
PMN infiltration was subsequently replaced by only a sparse infiltrate
of macrophages, which in the naive animals persisted for up to 13 weeks
p.i. In immune animals, the macrophages were absent by 72 h, a
finding concordant with the disappearance of spirochetal antigen. T and
B lymphocytes were detected during the time when EM lesions appeared in
infected naive animals (day 7 p.i.) but also following the time
that EM lesions had resolved (day 14 p.i.). After 13 weeks p.i., T
and B lymphoctytes were no longer detectable. By comparison, T and B
lymphocytes were never detected in the skin of challenged
infection-immune challenged animals. Taken together, these findings
show that in naive animals, the resolution of local skin infection
correlates with the infiltration of T and B lymphocytes as well as
macrophages, suggesting a primary role for cell-mediated immune
mechanisms at the time of borrelial clearance. The early inflammatory
response of PMNs and macrophages does not appear to affect the initial
establishment and persistence of spirochetal infection. By comparison,
no correlation was seen between the disappearance of viable spirochetes
and a cellular infiltrate of any particular immune cell type in the
immune rabbits following challenge, suggesting that humoral immunity
plays the primary role in the persistence of acquired resistance. This
is consistent with our recent study showing that passive immunization with serum from infection-immune rabbits can completely protect naive
rabbits against challenge with large numbers of virulent B. burgdorferi (12). Thus, both cell-mediated and
humoral immune mechanisms would appear to be important in the
development and persistence of acquired resistance that results during
the course of experimental rabbit Lyme disease.
In contrast to the rabbit model of Lyme disease, where infected animals
ultimately clear the infection and develop immunity to challenge
reinfection, infection in mice and humans is chronic. Thus, a
comparison of the immune response that occurs following infection in
mice with those in rabbits may provide insights into potential
differences that account for the development of immunity versus that of
chronic infection. In the mouse model, the host-immune response to
B. burgdorferi infection has been studied primarily in
BALB/c and C3H strains, the latter noted to be more permissive to
B. burgdorferi infection. The humoral arm of the murine
immune response has been thought to play a major role in the relative resistance of strains to Lyme disease while the cellular arm has been
demonstrated to influence the outcome of disease, including the
severity of arthritis (23). Following infection, BALB/c mice, the strain relatively more resistant to Lyme disease infection, are known to express an early predominant Th2 response (humoral immunity), whereas the more susceptible C3H mouse strain has an early
predominant Th1 response (cell-mediated immunity) (20, 21,
22). B. burgdorferi-infected C3H mice, compared
to infected BALB/c mice, harbor an increased spirochete burden in their
joints and concomitantly show a more severe level of arthritis. It has been suggested that differential cytokine production may contribute to
the mouse strain-related differences in susceptibility to Lyme disease
(22). In this regard, it has been shown that the ablation of the endogenous cytokine interleukin-12 (IL-12), which helps to
promote the development of a Th1 response, results in a reduced level
of arthritis. Conversely, the ablation of endogenous IL-6, which helps
to promote the Th2 response, results in an increased level of arthritis
(4). These findings suggest that, in the murine model,
humoral mechanisms are primarily responsible for the relative
resistance to infection, while a predominant cell-mediated immune
response is associated with increased disease severity. In contrast to
these studies, Zeidner and colleagues (47) have shown that
when susceptible mice are infected via the natural tick vector
(Ixodes scapularis), exogenously administered Th1 cytokines
reduce the severity of infection. Thus, the difference between chronic
infection in mice and complete immunity in rabbits may lie with
differences in the specific B. burgdorferi molecules recognized by the humoral and cell-mediated arms of immune response during infection.
We have recently shown that immune rabbits, but not rabbits
hyperimmunized with purified outer membrane from in vitro-cultivated borreliae, are completely protected following challenge using organisms
acquired from infected rabbit skin (36). We demonstrated that these organisms no longer express OspA and upregulate proteins that have been associated with host adaptation, such as OspC. These
findings suggest that upregulated and/or host-adapted borrelia specific
molecules are primarily responsible for the high degree of immunity
that results following rabbit infection (36). Several proteins have been identified previously in the murine model as being
upregulated during infection, including DbpA (10), OspC (35), and OspE and OspF (44). Proteins
identified as uniquely expressed during infection include EppA
(11), p35 and p37 (14), the OspE-F homologue
p21 (45), the OspF homologues bbk2.1 (3), pG
(46), and the proteins encoded on operon 2.9-7lpB
(2). Many of these proteins, however, have not shown great
potential as protective immunogens in the mouse model as a result of
either incomplete or no protection (14, 17) or due to
antigenic heterogeneity between strains which does not result in
heterologous cross-immunity (9, 19). Similarly, we have
found in the rabbit model no correlation between challenge immunity and
antibody detected against some of these proteins, including DbpA and
OspC (12, 36). However, the finding in this study that
rabbit skin infection results in large numbers of structurally intact
borrelia, which we have found to be host-adapted (36),
provides a rich source for identifying potentially new candidate
protective immunogens. Indeed, recent antigenic analysis of extracted
infected rabbit skin tissue has revealed several novel and strongly
antigenic molecules not detected using cultivated borreliae (J. N. Miller and M. A. Lovett, unpublished data). We are currently
studying the role these antigens may play in the clearance of
spirochetes during skin infection and the development of protective
immunity in the rabbit model of Lyme disease.
 |
ACKNOWLEDGMENTS |
This study was supported by NIH grant AI-37312 to J. N. Miller and NIH grant AI-29733 to M. A. Lovett.
We thank Xiao Yang Wu for his expert technical assistance and Jonathan
Said and Peter Shintaku for their guidance in the preparation and
interpretation of the histopathological sections.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Immunology, and Molecular Genetics, CHS 43-239, UCLA
School of Medicine, 10833 Le Conte Ave., Los Angeles, CA 90095. Phone: (310) 825-1979. Fax: (310) 206-3865. E-mail:
jmiller{at}mednet.ucla.edu.
Present address: Department of Pathology, University of California,
Irvine, College of Medicine, Irvine, CA 92797.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Ackermann, R.,
B. Rehse-Küpper,
E. Gollmer, and R. Schmidt.
1988.
Chronic neurologic manifestations of erythema migrans borreliosis.
Ann. N. Y. Acad. Sci.
539:16-23[CrossRef][Medline].
|
| 2.
|
Akins, D. R.,
K. W. Bourell,
M. J. Caimano,
M. V. Norgard, and J. D. Radolf.
1998.
A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state.
J. Clin. Investig.
101:2240-2250[Medline].
|
| 3.
|
Akins, D. R.,
S. F. Porcella,
T. G. Popova,
D. Shevchenko,
S. I. Baker,
M. Li,
M. V. Norgard, and J. D. Radolf.
1995.
Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue.
Mol. Microbiol.
18:507-520[CrossRef][Medline].
|
| 4.
|
Anguita, J.,
D. H. Persing,
M. Rincon,
S. W. Barthold, and E. Fikrig.
1996.
Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
J. Clin. Investig.
97:1028-1034[Medline].
|
| 5.
|
Anguita, J.,
D. H. Persing,
M. Rincon,
S. W. Barthold, and E. Fikrig.
1996.
Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
J. Clin. Investig.
97:1028-1034.
|
| 6.
|
Anguita, J.,
S. Samanta,
S. W. Barthold, and E. Fikrig.
1997.
Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice.
Infect. Immun.
65:4334-4336[Abstract].
|
| 7.
|
Barbour, A. G.
1984.
Isolation and cultivation of Lyme disease spirochetes.
Yale J. Biol. Med.
57:521-525[Medline].
|
| 8.
|
Barthold, S. W.,
D. S. Beck,
G. M. Hansen,
G. A. Terwilliger, and K. D. Moody.
1990.
Lyme borreliosis in selected strains and ages of laboratory mice.
J. Infect. Dis.
162:133-138[Medline].
|
| 9.
|
Bockenstedt, L. K.,
E. Hodzic,
S. Feng,
K. W. Bourrel,
A. de Silva,
R. R. Montgomery,
E. Fikrig,
J. D. Radolf, and S. W. Barthold.
1997.
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.
Infect. Immun.
65:4661-4667[Abstract].
|
| 10.
|
Cassatt, D. R.,
N. K. Patel,
N. D. Ulbrandt, and M. S. Hanson.
1998.
DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.
Infect. Immun.
66:5379-5387[Abstract/Free Full Text].
|
| 11.
|
Champion, C. I.,
D. R. Blanco,
J. T. Skare,
D. A. Haake,
M. Giladi,
D. Foley,
J. N. Miller, and M. A. Lovett.
1994.
A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection.
Infect. Immun.
62:2653-2661[Abstract/Free Full Text].
|
| 12.
|
Chong-Cerrillo, C.,
X.-Y. Wu,
Y.-P. Wang,
D. R. Blanco,
M. A. Lovett, and J. N. Miller.
2000.
Immune serum from rabbits infected with Borrelia burgdorferi B31 confers complete passive protection against homologous challenge.
J. Spiro. Tick-Borne Dis.
7:3-9.
|
| 13.
|
Duray, P. H.
1989.
Histopathology of clinical phases of human Lyme disease.
Rheum. Dis. Clin. N. Am.
15:691-710[Medline].
|
| 14.
|
Fikrig, E.,
S. W. Barthold,
W. Sun,
W. Feng,
S. R. Telford III, and R. A. Flavell.
1997.
Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.
Immunity
6:531-539[CrossRef][Medline].
|
| 15.
|
Foley, D. M.,
R. J. Gayek,
J. T. Skare,
E. A. Wagar,
C. I. Champion,
D. R. Blanco,
M. A. Lovett, and J. N. Miller.
1995.
Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity.
J. Clin. Investig.
96:965-975.
|
| 16.
|
Garcia-Monco, J. C., and J. L. Benach.
1989.
The pathogenesis of Lyme disease.
Rheum. Dis. Clin. N. Am.
15:711-726[Medline].
|
| 17.
|
Hagman, K. E.,
X. Yang,
S. K. Wikel,
G. B. Schoeler,
M. J. Caimano,
J. D. Radolf, and M. V. Norgard.
2000.
Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks.
Infect. Immun.
68:4759-4764[Abstract/Free Full Text].
|
| 18.
|
Hejka, A.,
J. L. Schmitz,
D. M. England,
S. M. Callister, and R. F. Schell.
1989.
Histopathology of Lyme arthritis in LSH hamsters.
Am. J. Pathol.
134:1113-1123[Abstract].
|
| 19.
|
Jauris-Heipke, S.,
R. Fuchs,
M. Motz,
V. Preac-Mursic,
E. Schwab,
E. Soutschek,
G. Will, and B. Wilske.
1993.
Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi.
Med. Microbiol. Immunol.
182:37-50[Medline].
|
| 20.
|
Kang, I.,
S. W. Barthold,
D. H. Persing, and L. K. Bockenstedt.
1997.
T-helper-cell cytokines in the early evolution of murine Lyme arthritis.
Infect. Immun.
65:3107-3111[Abstract].
|
| 21.
|
Keane-Myers, A.,
C. R. Maliszewski,
F. D. Finkelman, and S. P. Nickell.
1996.
Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
J. Immunol.
156:2488-2494[Abstract].
|
| 22.
|
Keane-Myers, A., and S. P. Nickell.
1995.
Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.
J. Immunol.
155:2020-2028[Abstract].
|
| 23.
|
Keane-Myers, A., and S. P. Nickell.
1995.
T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.
J. Immunol.
154:1770-1776[Abstract].
|
| 24.
|
Logigian, E. L.,
R. F. Kaplan, and A. C. Steere.
1990.
Chronic neurologic manifestations of Lyme disease.
N. Engl. J. Med.
323:1438-1444[Abstract].
|
| 25.
|
Matyniak, J. E., and S. L. Reiner.
1995.
T helper phenotype and genetic susceptibility in experimental Lyme disease.
J. Exp. Med.
181:1251-1254[Abstract/Free Full Text].
|
| 26.
|
Mbow, M. L.,
N. Zeidner,
N. Panella,
R. G. Titus, and J. Piesman.
1997.
Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes.
Infect. Immun.
65:3386-3390[Abstract].
|
| 27.
|
Moody, K. D.,
S. W. Barthold,
G. A. Terwilliger,
D. S. Beck,
G. M. Hansen, and R. O. Jacoby.
1990.
Experimental chronic Lyme borreliosis in Lewis rats.
Am. J. Trop. Med. Hyg.
42:165-174.
|
| 28.
|
Morbidity and Mortality Weekly Report.
1997.
Lyme disease United States, 1996.
Morbid. Mortal. Wkly. Rep.
46:531-535[Medline].
|
| 29.
|
Pachner, A. R.,
P. Duray, and A. C. Steere.
1989.
Central nervous system manifestations of Lyme disease.
Arch. Neurol.
46:790-795[Abstract].
|
| 30.
|
Pachner, A. R., and A. C. Steere.
1985.
The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.
Neurology
35:47-53[Abstract/Free Full Text].
|
| 31.
|
Philipp, M. T.,
M. K. Aydintug,
R. P. Bohm, Jr.,
F. B. Cogswell,
V. A. Dennis,
H. N. Lanners,
R. C. Lowrie, Jr.,
E. D. Roberts,
M. D. Conway,
M. Karaçorlu,
M Karacorlu,
G. A. Peyman,
D. J. Gubler,
B. J. B. Johnson,
J. Piesman, and Y. Gu.
1993.
Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.
Infect. Immun.
61:3047-3059[Abstract/Free Full Text].
|
| 32.
|
Preac Mursic, V.,
E. Patsouris,
B. Wilske,
S. Reinhardt,
B. Gross, and P. Mehraein.
1990.
Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.
Infection
18:332-341[CrossRef][Medline].
|
| 33.
|
Pride, M. W.,
E. L. Brown,
L. C. Stephens,
J. J. Killion,
S. J. Norris, and M. L. Kripke.
1998.
Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice.
J. Leukoc. Biol.
63:542-549[Abstract].
|
| 34.
|
Schmidli, J.,
T. Hunziker,
P. Moesli, and U. B. Schaad.
1988.
Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis.
J. Infect. Dis.
158:905-906[Medline].
|
| 35.
|
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913[Abstract/Free Full Text].
|
| 36.
|
Shang, E. S.,
C. I. Champion,
X. Y. Wu,
J. T. Skare,
D. R. Blanco,
J. N. Miller, and M. A. Lovett.
2000.
Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
Infect. Immun.
68:4189-4199[Abstract/Free Full Text].
|
| 37.
|
Sonnesyn, S. W.,
J. C. Manivel,
R. C. Johnson, and J. L. Goodman.
1993.
A guinea pig model for Lyme disease.
Infect. Immun.
61:4777-4784[Abstract/Free Full Text].
|
| 38.
|
Stanek, G.,
J. Klein,
R. Bittner, and D. Glogar.
1990.
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy.
N. Engl. J. Med.
322:249-252[Medline].
|
| 39.
|
Steere, A. C.
1989.
Lyme disease.
N. Engl. J. Med.
321:586-596[Abstract].
|
| 40.
|
Steere, A. C.,
W. P. Batsford,
M. Weinberg,
J. Alexander,
H. J. Berger,
S. Wolfson, and S. E. Malawista.
1980.
Lyme carditis: cardiac abnormalities of Lyme disease.
Ann. Intern. Med.
93:8-16.
|
| 41.
|
Steere, A. C.,
R. L. Grodzicki,
A. N. Kornblatt,
J. E. Craft,
A. G. Barbour,
W. Burgdorfer,
G. P. Schmid,
E. Johnson, and S. E. Malawista.
1983.
The spirochetal etiology of Lyme disease.
N. Engl. J. Med.
308:733-740[Abstract].
|
| 42.
|
Steere, A. C.,
S. E. Malawista,
J. A. Hardin,
S. Ruddy,
W. Askenase, and W. A. Andiman.
1977.
Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.
Ann. Intern. Med.
86:685-698.
|
| 43.
|
Steere, A. C.,
R. T. Schoen, and E. Taylor.
1987.
The clinical evolution of Lyme arthritis.
Ann. Intern. Med.
107:725-731.
|
| 44.
|
Stevenson, B.,
T. G. Schwan, and P. A. Rosa.
1995.
Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi.
Infect. Immun.
63:4535-4539[Abstract].
|
| 45.
|
Suk, K.,
S. Das,
W. Sun,
B. Jwang,
S. W. Barthold,
R. A. Flavell, and E. Fikrig.
1995.
Borrelia burgdorferi genes selectively expressed in the infected host.
Proc. Natl. Acad. Sci. USA
92:4269-4273[Abstract/Free Full Text].
|
| 46.
|
Wallich, R.,
C. Brenner,
M. D. Kramer, and M. M. Simon.
1995.
Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.
Infect. Immun.
63:3327-3335[Abstract].
|
| 47.
|
Zeidner, N.,
M. Dreitz,
D. Belasco, and D. Fish.
1996.
Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma.
J. Infect. Dis.
173:187-195[Medline].
|
| 48.
|
Zeidner, N.,
M. L. Mbow,
M. Dolan,
R. Massung,
E. Baca, and J. Piesman.
1997.
Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice.
Infect. Immun.
65:3100-3106[Abstract].
|
Infection and Immunity, June 2001, p. 4094-4102, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.4094-4102.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Crother, T. R., Champion, C. I., Whitelegge, J. P., Aguilera, R., Wu, X.-Y., Blanco, D. R., Miller, J. N., Lovett, M. A.
(2004). Temporal Analysis of the Antigenic Composition of Borrelia burgdorferi during Infection in Rabbit Skin. Infect. Immun.
72: 5063-5072
[Abstract]
[Full Text]
-
Stenmark, S., Sjostedt, A.
(2004). Transfer of specific antibodies results in increased expression of TNF-{alpha} and IL12 and recruitment of neutrophils to the site of a cutaneous Francisella tularensis infection. J Med Microbiol
53: 501-504
[Abstract]
[Full Text]
-
Labandeira-Rey, M., Seshu, J., Skare, J. T.
(2003). The Absence of Linear Plasmid 25 or 28-1 of Borrelia burgdorferi Dramatically Alters the Kinetics of Experimental Infection via Distinct Mechanisms. Infect. Immun.
71: 4608-4613
[Abstract]
[Full Text]